Cargando…

Large Neutral Amino Acids (LNAAs) Supplementation Improves Neuropsychological Performances in Adult Patients with Phenylketonuria

Phenylketonuria is an inborn error of phenylalanine (Phe) metabolism diagnosed by newborn screening and treated early with diet. Although diet prevents intellectual disability, patients often show impairment of executive functions, working memory, sustained attention, and cognitive flexibility. Larg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scala, Iris, Riccio, Maria Pia, Marino, Maria, Bravaccio, Carmela, Parenti, Giancarlo, Strisciuglio, Pietro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230959/ https://www.ncbi.nlm.nih.gov/pubmed/32326614 http://dx.doi.org/10.3390/nu12041092

Ejemplares similares

Beneficial Effects of Slow-Release Large Neutral Amino Acids after a Phenylalanine Oral Load in Patients with Phenylketonuria
por: Scala, Iris, et al.
Publicado: (2021)

Epigallocatechin-3-Gallate Plus Omega-3 Restores the Mitochondrial Complex I and F(0)F(1)-ATP Synthase Activities in PBMCs of Young Children with Down Syndrome: A Pilot Study of Safety and Efficacy
por: Scala, Iris, et al.
Publicado: (2021)

Long-term follow-up of patients with phenylketonuria treated with tetrahydrobiopterin: a seven years experience
por: Scala, Iris, et al.
Publicado: (2015)

Long-term treatment of phenylketonuria with a new medical food containing large neutral amino acids
por: Concolino, D, et al.
Publicado: (2017)

Erratum: Long-term treatment of phenylketonuria with a new medical food containing large neutral amino acids
por: Concolino, D, et al.
Publicado: (2017)

New Strategies for the Treatment of Phenylketonuria (PKU)
por: Strisciuglio, Pietro, et al.
Publicado: (2014)

Expanding the neurological and behavioral phenotype of White-Sutton syndrome: a case report
por: Donnarumma, Bernadette, et al.
Publicado: (2021)

The Impact of a Slow-Release Large Neutral Amino Acids Supplement on Treatment Adherence in Adult Patients with Phenylketonuria
por: Burlina, Alessandro P., et al.
Publicado: (2020)

Dystonic Movement Disorder as Symptom of Catatonia in Autism Spectrum Disorder
por: Riccio, Maria Pia, et al.
Publicado: (2020)

Distribution and age of onset of psychopathological risk in a cohort of children with Down syndrome in developmental age
por: Marino, M., et al.
Publicado: (2019)

Large Neutral Amino Acid Supplementation Exerts Its Effect through Three Synergistic Mechanisms: Proof of Principle in Phenylketonuria Mice
por: van Vliet, Danique, et al.
Publicado: (2015)

Bipolar disorder with Melnick–Needles syndrome and periventricular nodular heterotopia: two case reports and a review of the literature
por: Riccio, Maria Pia, et al.
Publicado: (2021)

Evaluation of Tetrahydrobiopterin Therapy with Large Neutral Amino Acid Supplementation in Phenylketonuria: Effects on Potential Peripheral Biomarkers, Melatonin and Dopamine, for Brain Monoamine Neurotransmitters
por: Yano, Shoji, et al.
Publicado: (2016)

Large neutral amino acid status in association with P:T ratio and diet in adult and pediatric patients with phenylketonuria
por: Douglas, Teresa D., et al.
Publicado: (2019)

Pitfalls and Risks of “New Eating Disorders”: Let the Expert Speak!
por: Salatto, Alessia, et al.
Publicado: (2023)

Effects of LC-PUFA Supplementation in Patients with Phenylketonuria: A Systematic Review of Controlled Trials
por: Couce, María Luz, et al.
Publicado: (2019)

Co-existence of Phenylketonuria and Fabry disease on a 3 year-old boy: case report
por: Concolino, Daniela, et al.
Publicado: (2010)

Dietary management of maternal phenylketonuria with glycomacropeptide and amino acids supplements: A case report
por: Pinto, A., et al.
Publicado: (2017)

Large Neutral Amino Acid Therapy Increases Tyrosine Levels in Adult Patients with Phenylketonuria: A Long-Term Study
por: Burlina, Alessandro P., et al.
Publicado: (2019)

The Benefit of Large Neutral Amino Acid Supplementation to a Liberalized Phenylalanine-Restricted Diet in Adult Phenylketonuria Patients: Evidence from Adult Pah-Enu2 Mice
por: van Vliet, Danique, et al.
Publicado: (2019)

Dietary amino acid intakes associated with a low-phenylalanine diet combined with amino acid medical foods and glycomacropeptide medical foods and neuropsychological outcomes in subjects with phenylketonuria
por: Stroup, Bridget M., et al.
Publicado: (2017)

Vitamin D deficiency is not related to eating habits in children with Autistic Spectrum Disorder
por: Riccio, Maria Pia, et al.
Publicado: (2020)

The Relation of Callous–Unemotional Traits and Bullying in Early Adolescence Is Independent from Sex and Age and Moderated by Conduct Problems
por: Catone, Gennaro, et al.
Publicado: (2021)

Is Quarantine for COVID-19 Pandemic Associated with Psychological Burden in Primary Ciliary Dyskinesia?
por: Riccio, Maria Pia, et al.
Publicado: (2020)

IAmHero: Preliminary Findings of an Experimental Study to Evaluate the Statistical Significance of an Intervention for ADHD Conducted through the Use of Serious Games in Virtual Reality
por: Schena, Annamaria, et al.
Publicado: (2023)

Bone Status in Patients with Phenylketonuria: A Systematic Review
por: de Castro, María José, et al.
Publicado: (2020)

Ensuring continuity of care for children with inherited metabolic diseases at the time of COVID-19: the experience of a metabolic unit in Italy
por: Brunetti-Pierri, Nicola, et al.
Publicado: (2020)

Good cognitive performances in a child with Prader-Willi syndrome
por: Nugnes, Rosa, et al.
Publicado: (2013)

Clinical and neuropsychological outcomes for children with phenylketonuria in Upper Egypt; a single-center study over 5 years
por: Sadek, Abdelrahim A, et al.
Publicado: (2018)

Phenylketonuria
por: Hudson, Frederick
Publicado: (1969)

Long-Term Metabolic Correction of Phenylketonuria by AAV-Delivered Phenylalanine Amino Lyase
por: Tao, Rui, et al.
Publicado: (2020)

Long-Term Metabolic Correction of Phenylketonuria by AAV-Delivered Phenylalanine Amino Lyase
por: Tao, Rui, et al.
Publicado: (2022)

Carbohydrate status in patients with phenylketonuria
por: Couce, María L., et al.
Publicado: (2018)

Optimising amino acid absorption: essential to improve nitrogen balance and metabolic control in phenylketonuria
por: MacDonald, Anita, et al.
Publicado: (2018)

In Vivo Metabolic Responses to Different Formulations of Amino Acid Mixtures for the Treatment of Phenylketonuria (PKU)
por: Giarratana, Nadia, et al.
Publicado: (2022)

Arterial stiffness assessment in patients with phenylketonuria
por: Hermida-Ameijeiras, Alvaro, et al.
Publicado: (2017)

Neuropsychological Disability in the Case of Natalizumab-Related Progressive Multifocal Leukoencephalopathy
por: Lo Buono, Viviana, et al.
Publicado: (2022)

Cerebellar Transcranial Direct Current Stimulation in Children with Autism Spectrum Disorder: A Pilot Study on Efficacy, Feasibility, Safety, and Unexpected Outcomes in Tic Disorder and Epilepsy
por: D’Urso, Giordano, et al.
Publicado: (2021)

Coexistence of cystic fibrosis and phenylketonuria.
por: Greeves, L. G., et al.
Publicado: (1997)

Phenylketonuria: nutritional advances and challenges
por: Giovannini, Marcello, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_c22bp79fg02496pmr92mcl5btj